🇩🇪 Germany Country × Condition
multiple myeloma Clinical Trials in Germany
Active clinical trials for multiple myeloma with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇩🇪 Germany
Active Trials in Germany (2)
NCT03761108 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Enrollment
387 pts
Country
🇩🇪 Germany
Regeneron Pharmaceuticals
View Trial → NCT05695508 Phase 2
Recruiting
GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5
Enrollment
160 pts
Country
🇩🇪 Germany
University of Heidelberg Medical Ce...
View Trial → Frequently Asked Questions
How many multiple myeloma clinical trials are active in Germany?
There are currently 2 active clinical trials for multiple myeloma with sites in Germany, of which 2 are actively recruiting patients.
How can I join a multiple myeloma clinical trial in Germany?
To join a multiple myeloma clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple myeloma trials in Germany?
Active multiple myeloma trials in Germany span Phase 1, Phase 2, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.